• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CAQH CORE Approves Two-day Rule to Accelerate Prior Authorization Process

Share:

February 12, 2020

Highlights on this story:
  • CAQH CORE participating organizations–consisting of healthcare providers, health plans, vendors, government entities, associations and standard-setting organizations–have come together to pass a national two-day time limit for plans to request additional info and make final decisions on prior authorization requests.
  • Prior authorizations are the most costly, time-consuming administrative transaction for providers. And when the process takes too long, it can delay patient care.
  • Over 80 percent of industry stakeholders agree to time limits on requests for supporting information and final determinations on prior authorizations.

CAQH CORE, a multi-stakeholder organization representing a broad spectrum of health plans, providers, vendors, and government entities, has voted to set two-day time limits on how quickly health plans must request additional supporting information from providers and make final determinations on prior authorization requests.

With this operating rule, CAQH CORE participating organizations agreed to update requirements in the CAQH CORE 278 Prior Authorization Infrastructure Rule. The new requirements set national expectations for prior authorization turnaround times using the HIPAA-mandated standard to move the industry toward greater automation.

Establishes Maximum Timeframes at Key Stages in the Prior Authorization Process

In particular, the updated operating rule establishes maximum timeframes at key stages in the prior authorization process for both batch and real-time transactions:

Two-Day Additional Information Request: A health plan, payer or its agent has two business days to review a prior authorization request from a provider and respond with the additional documentation needed to complete the request.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Two-Day Final Determination: Once all requested information has been received from a provider, the health plan, payer or its agent has two business days to send a response containing a final determination.

Optional Close-Out: A health plan, payer or its agent may choose to close out a prior authorization request if the additional information needed to make a final determination is not received from the provider within 15 business days of communicating what additional information is needed.

Why It Matters

Prior authorizations are the most costly, time-consuming administrative transaction for providers. And when the process takes too long, it can delay patient care.

Under this operating rule, the timeframe requirements must be met 90 percent of the time in a calendar month. This updated rule, coupled with the release of the CAQH CORE 278 Prior Authorization Data Content Rule in May 2019, enhances the information sent in the HIPAA-mandated standard electronic transaction and allow for faster responses. CORE Certification is now available for entities to demonstrate conformance with the CAQH CORE Prior Authorization Operating Rules and show commitment to greater prior authorization automation.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Research: Half of Hospital Leaders Plan to Invest in AI by 2021Research: Half of Hospital Leaders Plan to Invest in AI by 2021
  • AI’s Future In Healthcare Is Not Entirely RosyAI’s Future In Healthcare Is Not Entirely Rosy
  • Rho Selects Medidata’s Decentralized Clinical Trials CapabilitiesRho Selects Medidata’s Decentralized Clinical Trials Capabilities
  • RefleXion Medical Raises $125M for Biology-Guided RadiotherapyRefleXion Medical Raises $125M for Biology-Guided Radiotherapy
  • Morgan Stanley Capital Partners acquires environmental services companyMorgan Stanley Capital Partners acquires environmental services company
  • Predicting Drug Safety Through Systems ToxicologyPredicting Drug Safety Through Systems Toxicology
  • Garmin Launches New Connected Scale That can Give Users Trends Over TimeGarmin Launches New Connected Scale That can Give Users Trends Over Time
  • Lantheus To Acquire Progenics To Form A Leading Precision Diagnostics Imaging And Therapeutics CompanyLantheus To Acquire Progenics To Form A Leading Precision Diagnostics Imaging And Therapeutics Company

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications